Fresenius Kabi Oncology Ltd has informed BSE that the promoter of the Company i.e. Fresenius Kabi (Singapore) Pte Ltd. has made a public announcement to the public shareholders of Fresenius Kabi Oncology Limited (?Company?) in respect of the proposed acquisition and consequent delisting of the fully paid-up equity shares of the Company from the BSE Limited (?BSE?) and the National Stock Exchange of India Limited (?NSE?) in accordance with the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 (?Delisting Regulations?).
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
